GROWTH FAILURE
Clinical trials for GROWTH FAILURE explained in plain language.
Never miss a new study
Get alerted when new GROWTH FAILURE trials appear
Sign up with your email to follow new studies for GROWTH FAILURE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Liver disease growth study pulled before it began
Disease control TerminatedThis study planned to test a drug called Increlex (a growth factor) in children aged 4 to 18 with chronic liver disease and short stature. The goal was to see if it could help them grow better and improve their quality of life. However, the study was withdrawn before any particip…
Matched conditions: GROWTH FAILURE
Phase: NA • Sponsor: University of California, Los Angeles • Aim: Disease control
Last updated May 26, 2026 12:03 UTC
-
Protein boost in breast milk may help tiniest babies thrive
Disease control OngoingThis study looks at whether giving extra protein in human milk during the first two weeks of life helps extremely preterm infants (born at 28 weeks or earlier) gain more lean body mass and develop a healthier mix of gut bacteria. About 150 babies will take part. The goal is to im…
Matched conditions: GROWTH FAILURE
Phase: NA • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated May 22, 2026 13:50 UTC
-
Tiny tummies, big clues: can poop predict preemie disease?
Knowledge-focused OngoingThis study follows 300 premature babies born before 33 weeks to learn why some develop serious conditions like necrotizing enterocolitis, lung disease, or growth problems. Researchers analyze bacteria and molecules from the babies' stool, blood, and urine, as well as their DNA fr…
Matched conditions: GROWTH FAILURE
Sponsor: University of California, Davis • Aim: Knowledge-focused
Last updated May 26, 2026 12:01 UTC